About the Journal
This is the Journal of Endovascular Resuscitation and Trauma Management (JEVTM). We want to provide a truly Open Access platform for the dissemination of knowledge and peer-reviewed research in the field of endovascular and hybrid hemorrhage control.
To achieve this, we do not wish to be bound by medical discipline, country, resource or even the conventional rules of medical publishing. To achieve this goal, we have assembled an Editorial Board of clinicians and scientists who are experts within the field. This project is generously supported by a grant from the Department of Cardiothoracic and Vascular Surgery, Orebro University Hospital, Sweden.
We are keen to receive manuscript submissions that present new original findings, review important topics or educate our readers on any aspect of hemorrhage control, where an endovascular technique has been employed. This can either be in isolation or in combination with open surgical techniques (hybrid surgery). Please see the section “For Authors".
As the subject of hemorrhage and bleeding is a common problem across many medical disciplines, we encourage submissions from all specialties: vascular, trauma, acute care, obstetrics, emergency medicine, to mention a few.
The Journal will be published every four months and will be truly Open Access. There will be no article processing charges or publishing fees. All articles will be published online and indexed using a digital object identifier. The Archives can be found on www.jevtm.com under journals and are there with no time or access limitations.
The journal is indexed by Web of Science and Scopus.
Attendning Vascular Surgeon, General Surgeon
Associate Prof of Surgery
Department of Cardiothoracic and Vascular Surgery, Deptment of Surgery
Örebro University Hospital and University
701 85 Örebro
Policies of the JEVTM
While the journal makes every effort to ensure the accuracy and integrity of published manuscripts, the journal and its editors take no responsibility for content published. Where material is recognized to be incorrect post-publication, an erratum will be published or the material withdrawn.
Ethics and disclosures
The journal is committed to maintaining the highest level of integrity in the content published.
This journal has a Conflict of Interest policy in place and complies with international, national and/or institutional standards on research involving Human Participants and/or Animals and Informed Consent.
The journal follows the Committee on Publication Ethics (COPE) reccomendations and subscribes to its principles on how to deal with acts of misconduct thereby committing to investigate allegations of misconduct in order to ensure the integrity of research. The journal is commited to ensure that the potential for advertising has no impact or influence on the content of the journal or editorial decisions.
The journal may use plagiarism detection software to screen the submissions. If plagiarism is identified, the COPE guidelines on plagiarism will be followed. The editorial policies of the journal encourages transparency and honest reporting as well as ensure that peer reviewers and authors have a clear understanding of what is expected of them as stated in the reviewer electronic statement and instructions for authors. The editorial office use the journal’s standard electronic submission system for all journal communications. The information in the journal system is confidential and submitted material can not be used in any way but by the authors.
Content published in this journal is peer reviewed (Double Blind) and all reviewers declare conflict of interest during the review process.
More information can be found in the section For Authors.
Article Submission Types
This sections outlines the broad categories of manuscripts which can be submitted to the Journal:
- Original Article: This is a report of a formal basic science or clinical research study (max word count: 3000).
- Editorial: This is expert overview of an important scientific or specialty related subject (max word count: 1500)
- Narrative Review Article: This should present an overview of the literature on a subject of relevance to endovascular hemorrhage control (max word count: 5000).
- Systematic Review and Meta-Analyses: On subjects where there is sufficient evidence to present a pooled analysis, a systematic review (with or without) a meta-analysis is preferred over a narrative review (max word count: 5000).
- Tips and Techniques: This type of article permits the author to write from experience, rather than from the published literature. Articles explaining how to approach certain problems or how to accomplish certain maneuvers are welcomed (max word count: 1500).
- Images of Interest: we are keen to present radiological image(s) accompanied by a short narrative that have an educational message (max word count: 250).
- Case reports: Short case reports with current literature reviews (1500)
- Conference Proceedings: Where a conference is affiliated to the Journal, the proceedings will be published as agreed by the Editorial Board.
- Letters to the Editor: Letters for publication can be written to the Editor that comment on anything within the journal.
- Resident corner: Short article managed and written by residents (no senior authors) with educational value (max word count 1500)
The Journal is an evolving entity and we are interested to hear from authors with novel manuscript ideas, and notes of interest should be sent to the Managing Editor.
The Journal operates a double blinded review policy, where the identity of the authors and reviewers are concealed. Manuscripts will be reviewed by a minimum of two reviewers and, where consensus is not achieved, a third reviewer will be invited. All submission reviews and outcomes aim to be completed within six weeks of submission. There are four categories of outcome:
- Acceptance without changes manuscripts will be sent straight for copy editing and typesetting without changes to the academic content. This is unusual.
- Acceptance with minor changes manuscripts will require minor changes to the academic content, which will be re-assessed at the editorial level.
- Invitation to re-submit following major changes this category applies to manuscripts which are of interest to the Journal, but require major changes and a further round of peer review. Acceptance is not guaranteed at this stage.
- Rejection this may occur at the Editorial level or following peer review. Effort will be made to explain the decision-making in order that authors can improve their manuscript and overall scientific approach.
In order to review for the Journal, reviewers will be one of the following:
- An active basic science or clinical researcher in the field of endovascular hemorrhage control, preferably with a formal academic appointment.
- An experienced clinician actively practicing in the field of endovascular hemorrhage control.
- A non-medical individual with specialist knowledge and experience.
The Journal also recognizes that early career scientists can and should contribute to the peer-review process. This can be undertaken in a mentored way, so that the process is robust and beneficial to the reviewer. Notes of interest should be sent to the Managing Editor.
The Journal editors have the final say on manuscript acceptance.
In order to support the open access nature of the Journal, content is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License .
This means that published articles can be distributed, without restriction, in any medium or format, for any purpose, even commercially. This is subject to the following conditions:
- Attribution - use of any material from the Journal must be appropriately referenced.
- No Derivatives - material must not be modified.
The Journal is funded very generously by the University Hospital of Örebro and the hospital reaserch council as well as the EVTM research group. This permits professional IT and publishing support, but all other roles are gratis. Should any other organisation or individual wish to financially contribute to the running of this open-access endeavor, please contact the Managing Editor.